Cytosorbents CorporationCTSONASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank67
3Y CAGR+86.5%
5Y CAGR-10.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+86.5%/yr
vs -40.9%/yr prior
5Y CAGR
-10.5%/yr
Recent acceleration
Acceleration
+127.4pp
Accelerating
Percentile
P67
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$18.13M-
2024$0.00-100.0%
2023$38.31M+1271.1%
2022$2.79M-92.7%
2021$38.48M+22.1%
2020$31.51M+28.8%
2019$24.47M+7.0%
2018$22.88M+48.3%
2017$15.43M+25.6%
2016$12.28M-